Changes in lymphocyte beta 2-adrenoceptors after hepatic resection. 1995

H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
Second Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

Hepatic resection promotes such a high degree of surgical stress that it induces deterioration of various vital functions, which may involve the breakdown of signal transduction systems. To investigate the influence of surgical stress on signal transduction, we studied ligand-receptor specific binding activity after hepatic resection, focusing on lymphocyte beta 2-adrenoceptors. The maximum binding capacity (Bmax) and the dissociation constant (KD) were determined by radioligand binding assay using (-)3H-CGP12177 as a ligand. In the hepatectomy group, Bmax significantly decreased from 1380 +/- 109 to 799 +/- 49 receptors/cell on postoperative day (POD) 3 and to 802 +/- 93 receptors/cell on POD 7 (P < 0.05). In the control group, however, it did not significantly change after the operation. No significant changes in KD were found in either of these groups. The Bmax alteration was not due to the redistribution of lymphocyte subsets or receptor down regulation, but to the decrease in the Bmax of the individual subset. The hepatectomy group was divided into two groups according to the postoperative arterial ketone body ratio (AKBR): Group A, AKBR maintained at 0.7 or more; and Group B, AKBR decreased to below 0.7. The Bmax decrease, a percentage of the preoperative value, of Group B was significantly smaller than that of Group A (48.4 +/- 3.9 and 72.3 +/- 7.3%, respectively, P < 0.05). These results suggest that intense surgical stress, produced by hepatic resection, may influence even ligand-receptor binding parameters, and the decrease in AKBR can indicate the magnitude of surgical stress.

UI MeSH Term Description Entries
D007657 Ketone Bodies The metabolic substances ACETONE; 3-HYDROXYBUTYRIC ACID; and acetoacetic acid (ACETOACETATES). They are produced in the liver and kidney during FATTY ACIDS oxidation and used as a source of energy by the heart, muscle and brain. Acetone Bodies,Bodies, Acetone,Bodies, Ketone
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D005260 Female Females

Related Publications

H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
December 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
December 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
January 1989, Clinical pharmacology and therapeutics,
H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
January 1990, Gynecologic and obstetric investigation,
H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
January 1993, Biological psychiatry,
H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
June 1992, Gastroenterology,
H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
January 1990, Acta obstetricia et gynecologica Scandinavica,
H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
February 1993, British journal of pharmacology,
H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
September 1992, Lancet (London, England),
H Terajima, and K Mori, and T Taniguchi, and M Sugano, and M Kanai, and F Nishizawa, and T Morimoto, and T Inamoto, and Y Yamaoka, and K Ozawa
December 1984, British journal of clinical pharmacology,
Copied contents to your clipboard!